Jannine Versi
Director/Board Member chez DMK PHARMACEUTICALS CORPORATION
Fortune : 230 $ au 31/03/2024
Profil
Jannine C.
A Versi was the founder of My Elektra, Inc. founded in 2019, where she held the title of Chief Operating Officer.
Currently, she is a Director at DMK Pharmaceuticals Corp.
since 2023.
Jannine's former job was as a Director at DMK Pharmaceuticals Corp.
(Old).
Jannine's education includes an undergraduate degree from the University of Pennsylvania and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/10/2023 | 2 481 ( 0,02% ) | 129 $ | 31/03/2024 | |
| 06/10/2023 | 1 941 ( inf% ) | 101 $ | 31/03/2024 |
Postes actifs de Jannine Versi
| Sociétés | Poste | Début |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Director/Board Member | 25/05/2023 |
My Elektra, Inc.
 My Elektra, Inc. Internet Software/ServicesTechnology Services My Elektra, Inc. provides women to take hormonal health journey. The company was founded in 2019 by Alessandra Henderson and Jannine Versi and is headquartered in Brooklyn, NY. | Founder | 01/01/2019 |
Anciens postes connus de Jannine Versi
| Sociétés | Poste | Fin |
|---|---|---|
DMK Pharmaceuticals Corp. (Old)
 DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Director/Board Member | - |
Formation de Jannine Versi
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
My Elektra, Inc.
My Elektra, Inc. Internet Software/ServicesTechnology Services My Elektra, Inc. provides women to take hormonal health journey. The company was founded in 2019 by Alessandra Henderson and Jannine Versi and is headquartered in Brooklyn, NY. | Technology Services |
DMK Pharmaceuticals Corp. (Old)
DMK Pharmaceuticals Corp. (Old) BiotechnologyHealth Technology DMK Pharmaceuticals Corp. (Old) was an American commercial stage neuro-biotech company that focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders. The company's approved products included Zimhi® (naloxone) injection for the treatment of opioid overdose and Symjepi® (epinephrine) injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company was founded by Neil M. Frazer and Ebrahim Versi. DMK Pharmaceuticals Corp. was acquired by DMK Pharmaceuticals Corp. on May 25, 2023 for $27 million. | Health Technology |
